News Coverage

Panitch Schwarze Client Tekcapital Files for a Patent for Potential Treatment of Coronavirus Patients

February 13, 2020

Tekcapital PLC said Monday its investee, Belluscura PLC and their research partner Separation Design Group, has filed for a patent application for an oxygen enrichment device that treats patients with acute respiratory distress including patients suffering from coronavirus.

"We are pleased to see the additional progress of Belluscura as it continues to strengthen its intellectual property in the oxygen therapy space to help patients afflicted with acute respiratory distress caused by the Coronavirus, said Clifford Gross, Executive Chairman of Tekcapital.

Panitch Schwarze Belisario & Nadel LLP partner Dennis J. Butler supports clients, including Tekcapital with intellectual property and technology law. Butler’s practice includes representing clients before the U.S. Patent and Trademark Office and foreign patent offices. 

To learn more, visit London based outlets Morning Star and Vox Markets.


Contact Us

By checking this box, I agree to the terms and conditions outlined on our Disclaimer page.
Email Disclaimer

Sending an email to our office does not create an attorney-client relationship, and none will be formed unless there is an expressed agreement between the firm and the client. Thus, we strongly advise against sending confidential or privileged information to us until you can establish such a relationship. Furthermore, we advise against sending privileged or confidential information through email at all, since we can in no way ensure the security of your email. In fact, neither this website nor the email system involved is encrypted, so you should not assume that your email is confidential. We cannot guarantee that someone else will not see it.

Do you agree to this Email Disclaimer?

I Agree I Do Not Agree